The 2025 ISG Provider Lens ® AI-Driven ADM Services report for the U.S. finds that organizations are embedding AI and automation into every layer of ADM operations to make applications more resilient ...
Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties.
Researchers announce breakthrough results for AMT-130, the first disease-modifying treatment for Huntington's disease, with ...
News-Medical.Net on MSN
Nemours neurologist wins major NIH award to study hippocampal dysfunction in brain disorders
Rodney Scott, MBChB, MRCP, DipStat, PhD, Division Chief of Neurology, Nemours Children's Health, Delaware Valley, has ...
The Delhi High Court set aside the Rs. 450 Crore anti-profiteering order against Tata Play Ltd., upholding the constitutional validity of Section 171 but remanding the factual dispute to GSTAT for ...
There is no cure for Huntington's disease, but a new gene treatment is the first to significantly slow the symptoms in human ...
Restoration Hardware’s plans to homogenize the exterior of a building in Old Town Los Gatos was approved. South Bay ...
The decision was carried by a 4 to 2 vote, with one abstention. First-term member Shannon Troncoso and Donald Patton offered ...
This article covers when attorney-client privilege in New York protects communications. Privilege generally lasts if ...
Moving into AI-first development is a journey, and we're all learning together. I want to share some bittersweet lessons from ...
Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...
Nigeria's persistent and deep-rooted national security failures demand a fundamental re-evaluation and transformation of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results